Korea

VUNO presents its state-of-the-art AI medical imaging technology at ECR 2021

SEOUL, South Korea, March 2, 2021 /PRNewswire/ -- VUNO Inc., South Korean AI medical imaging company, will showcase its complete deep learning-based imaging offerings two years in a row in its virtual booth at the 2021 European Congress of Radiology (ECR), one of the biggest annual events, featur...

2021-03-02 23:00 1618

LISCure Biosciences Successfully Raises $21 million in Series B Funding

SEOUL, South Korea, Feb. 26, 2021 /PRNewswire/ -- On February 25th, 2021, LISCure Biosciences Inc., a biotech company that focuses on developing bacteria-mediated immunotherapy, announced that it has successfully completed $21 million of a Series B funding round. Participants include institutional...

2021-02-26 22:00 3279

Genome & Company and Debiopharm Join Forces To Create New Highly Specific Therapies for Cancer Patients

SEOUL, South Korea, Feb. 24, 2021 /PRNewswire/ -- Genome & Company (314130, CEO: Jisoo Pae, Hansoo Park), a global leading immuno-oncology firm, and Debiopharm, a Swiss-based biopharmaceutical company specializing in oncology and infectious diseases, today announced having entered into a research ...

2021-02-25 07:00 2172

Hyundai Motor Group Appoints Ben Diachun as Chief Technology Officer for Urban Air Mobility Division

* Aerospace start-up veteran to lead Division's growing R&D and engineering operation, lead technological innovation * Diachun brings 20 years of experience in building sustainable high-growth companies and helping develop revolutionary aerospace vehicles SEOUL, South Korea and WASHINGTON, Fe...

2021-02-23 22:10 3800

Curocell announces Korean FDA clearance of the IND for CRC01, a first in kind immune checkpoint receptors downregulated CD19 CAR-T therapy

DAEJEON, South Korea, Feb. 22, 2021 /PRNewswire/ -- Curocell, Inc., a clinical-stage biotech developing next-generation CAR-T (OVIS™) therapies, announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved its Phase 1/2 clinical study application forCRC01, CD19 CAR-T cell the...

2021-02-22 22:00 1357

Hyundai Mobis' HLED to perform tail and stop light with a single LED for the first time in the world

* Performing both tail and stop light functions with a single LED * Securing a uniform bright light with a 5.5mm-thick film even it is bent or curved * Lighter, smaller LED lamps… various pattern designs are also possible * Will lead the global lamp market with emotional and functional sati...

2021-02-22 16:10 1491

Samsung Display Kick-starts ESG* Management with joining RBA Membership

SEOUL, South Korea, Feb. 20, 2021 /PRNewswire/ -- Samsung Display Chief Executive OfficerJoo Sun Choi announced that the company will further boost its environmental, social and governance (ESG) involvement from 2021. Samsung Display joined RBA membership to take the initiative among local displ...

2021-02-21 07:00 2616

MAXST officially Launched Spatial AR Platform Technology

SEOUL, South Korea, Feb. 9, 2021 /PRNewswire/ -- On February 9th 2021, MAXST launched an official website of 'MAXST VPS' (vps.maxst.com ), a spatial AR platform, MAXST VPS. MAXST officially launched spatial AR platf...

2021-02-09 22:00 1716

EnGIS Technologies joins the Uptane project further strengthening its Over-The-Air (OTA) cybersecurity

SEOUL, South Korea, Feb. 8, 2021 /PRNewswire/ -- EnGIS Technologies, a leading supplier of automotive software solutions, announced today that it has joined the Uptane project under the Joint Development Foundation. EnGIS has already begun work on integrating the Uptane framework into its EnAIR O...

2021-02-08 20:12 1330

KineMaster Ranked No. 5 Among Korea's Top Mobile Publishers in Global Downloads

SEOUL, South Korea, Feb. 4, 2021 /PRNewswire/ -- App Annie, an industry-trusted mobile data and analytics platform, announced the list of the world's top publishers through the Level Up Top Publishers Awards of 2021. KineMaster was ranked No....

2021-02-05 08:00 1639

CUBRID launches CUBRID 11, Open Source DBMS for OLTP

SEOUL, South Korea, Feb. 3, 2021 /PRNewswire/ -- CUBRID is pleased to announce the release of CUBRID11, the latest stable version of the CUBRID DB engine. The CUBRID 11 focuses on performance improvement, new features adding, and security and convenience enhancement. In the meantime, CUBRID 11.0...

2021-02-04 01:00 1431

Mando agrees to acquire Mando Hella Electronics (MHE) and expects synergy in the autonomous driving business

SEOUL, South Korea, Feb. 3, 2021 /PRNewswire/ -- On February 3rd, Mando, a leading company in automotive parts, has signed a share purchase agreement (SPA) to acquire 100% of the equity in MHE, a joint venture between Halla Holdings of Korea and HELLA. MHE, founded in 2008, is a joint venture be...

2021-02-03 22:00 6006

ILIAS Biologics announces the 2nd POC study, showing anti-inflammatory effects of ILB202 on preterm birth

DAEJEON, South Korea, Feb. 1, 2021 /PRNewswire/ -- ILIAS Biologics, Inc. announced that its latest research in collaboration with researchers at The University of Texas Medical Brand at Galveston (UTMB) is published in the journalScience Advances(Link: https://advances.sciencemag.org/content/7/4/...

2021-02-02 02:00 1493

Top University Leaders Urge Innovation for the Post-COVID Era at the KAIST Summit

DAEJEON, South Korea, Jan. 31, 2021 /PRNewswire/ -- Universities are facing ever-mounting pressure to address impacts brought on by COVID-19 and the emerging technologies of the Fourth Industrial Revolution (4IR). KAIST summit about the Post-CO...

2021-02-01 08:00 1353

Immunoforge's 'PF1801' Is Designated as Orphan Drug by FDA

SEOUL, South Korea, Jan. 28, 2021 /PRNewswire/ -- Immunoforge, the company specializing in the development of new drugs for rare musculoskeletal diseases (Representatives: An Seong-Min and Jang Gi-Ho), announced that their new drug candidate PF1801 has been designated as the FDA orphan drug for t...

2021-01-28 22:00 1918

Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA

INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the company's track record as a premiere CDO serv...

2021-01-27 08:26 6104

Maypharm Announces New Product METOX on Times Square in New York

SEOUL, South Korea and NEW YORK, Jan. 26, 2021 /PRNewswire/ -- Maypharm announces new botulinum toxin, METOX onJanuary 26, 2021. METOX is an effective solution for smoothing any kind of wrinkles from moderate to severe, caused by daily active facial movements.

2021-01-26 17:00 1457

Samsung Biologics Reports 66% Increase in 2020 Revenue Achieving "1 Trillion Won" Target Sales

INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) reported its fourth quarter and full-year 2020 financial results indicating strong business performance, benefitting from increased sales across all plants and significant business agility and operating excelle...

2021-01-26 15:00 6200

FIPS-140-2 CMVP certification on super-density 8TB military-grade SSD

SEOUL, South Korea, Jan. 15, 2021 /PRNewswire/ -- Novachips Co., Ltd., an innovator in flash storage solution, today announced that it had acquired Federal Information Processing Standard (FIPS) 140-2 Level 2 (Cert# 3785) certification on its mainstream Scalar (SATA-based) and Express (NVMe-based...

2021-01-16 01:00 2925

MakinaRocks, Hyundai Robotics sign MOU to 'advance AI-based industrial robot arm anomaly detection'

SEOUL, South Korea, Jan. 14, 2021 /PRNewswire/ -- Enterprise AI solution provider, MakinaRocks (http://makinarocks.ai ) announced the signing of a memorandum of understanding (MOU) with Hyundai Robotics onJanuary 14, regarding the cooperation of the two companies in devel...

2021-01-14 14:52 1390
1 ... 90919293949596 ... 110